Firmenbeschreibung
Vertex Pharmaceuticals Inc. ist ein globales Biotech-Unternehmen, das sich der Entdeckung und Entwicklung kleinmolekularer Arzneimittel zur Behandlung von schweren Erkrankungen verschrieben hat. Die Strategie des Unternehmens besteht aus der Vermarktung seiner Produkte sowohl unabhängig als auch gemeinsam mit führenden Pharmakonzernen. Die Produktpipeline von Vertex ist hauptsächlich auf Virusinfektionen, Entzündungen, Autoimmunkrankheiten und Krebs ausgerichtet. Vertex vermarktet den HIV-Proteasehemmer Lexiva gemeinsam mit GlaxoSmithKline.
KeyData
| endOfFinancialYear: | 31.12.2022 01:00 |
| stockholderStructure: | Freefloat (82.7%),BlackRock, Inc. (9.4%),The Vanguard Group (7.9%) |
| sharesOutstanding: | 257551600.0000 |
| ceo: | Reshma Kewalramani, M.D. |
| board: | Charles F. Wagner, Jr., Amit K. Sachdev, Bastiano Sanna, Ph.D., Carmen Bozic, M.D., Damian Wimot, Dr. David Altshuler, Dr. Jeffrey Leiden, Joy Liu, Ludovic Fenaux, Mark Bunnage, Michael Partridge, Mike Tirozzi, Nia Tatsis, Ph.D., Nina Devlin, Paul Negulescu, Stephanie Franklin, Stuart A. Arbuckle |
| supervisoryBoard: | Dr. Jeffrey Leiden, Bruce I. Sachs, Diana McKenzie, Dr. Alan Garber, Dr. Sangeeta N. Bhatia, Lloyd Carney, Margaret McGlynn, Reshma Kewalramani, Terrence C. Kearney, Yuchun Lee |
| countryID: | 20 |
| freeFloat: | 82.7000 |
| faceValue: | 0.0100 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Michael Partridge |
| phone: | +1-617-444-0585 |
| email: | investorinfo@vrtx.com |
| irWebSite: | https://investors.vrtx.com/ |
Adresse
| street: | 50 Northern Avenue |
| city: | Boston, Massachusetts 02210, USA |
| phone: | +1-617-341-6100 |
| webSite: | www.vrtx.com/ |
Finanzen (kurz)
| year: | 2020 | cash: | 5988.1870 |
| balanceSheetTotal: | 11751.8080 | liabilities: | 3064.9930 |
| totalShareholdersEquity: | 8686.8150 | sales: | 6205.6830 |
| investment: | 22.2000 | incomeBeforeTaxes: | 3116.7980 |
| netIncome: | 2711.6470 | cashFlow: | 2868.1640 |
| employees: | 3400 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2021 | cash: | 6795.0000 |
| balanceSheetTotal: | 13432.5000 | liabilities: | 3332.5000 |
| totalShareholdersEquity: | 10100.0000 | sales: | 7574.4000 |
| investment: | 4.9000 | incomeBeforeTaxes: | 2730.4000 |
| netIncome: | 2342.1000 | cashFlow: | 811.2000 |
| employees: | 3900 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2022 | cash: | 10504.0000 |
| balanceSheetTotal: | 18150.9000 | liabilities: | 4238.2000 |
| totalShareholdersEquity: | 13912.7000 | sales: | 8930.7000 |
| incomeBeforeTaxes: | 4232.4000 | netIncome: | 3322.0000 |
| cashFlow: | 3711.9000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
Finanzen (kurz)
| year: | 2020 |
| cash: | 5988.1870 |
| balanceSheetTotal: | 11751.8080 |
| liabilities: | 3064.9930 |
| totalShareholdersEquity: | 8686.8150 |
| sales: | 6205.6830 |
| investment: | 22.2000 |
| incomeBeforeTaxes: | 3116.7980 |
| netIncome: | 2711.6470 |
| cashFlow: | 2868.1640 |
| employees: | 3400 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2021 |
| cash: | 6795.0000 |
| balanceSheetTotal: | 13432.5000 |
| liabilities: | 3332.5000 |
| totalShareholdersEquity: | 10100.0000 |
| sales: | 7574.4000 |
| investment: | 4.9000 |
| incomeBeforeTaxes: | 2730.4000 |
| netIncome: | 2342.1000 |
| cashFlow: | 811.2000 |
| employees: | 3900 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 10504.0000 |
| balanceSheetTotal: | 18150.9000 |
| liabilities: | 4238.2000 |
| totalShareholdersEquity: | 13912.7000 |
| sales: | 8930.7000 |
| incomeBeforeTaxes: | 4232.4000 |
| netIncome: | 3322.0000 |
| cashFlow: | 3711.9000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 | units: | 1000000 |
| balanceSheetTotal: | 13432.5000 | cash: | 6795.0000 |
| currentAssets: | 9560.6000 | fixedAssets: | 3871.9000 |
| liabilities: | 2142.0000 | totalLiabilitiesEquity: | 13432.5000 |
| totalShareholdersEquity: | 10100.0000 | employees: | 3900 |
| property: | 1094.1000 | inventories: | 353.1000 |
| accountsReceivable: | 1136.8000 | currentSecurities: | 729.9000 |
| accountsPayable: | 195.0000 | liabilitiesBanks: | 0.0000 |
| liabilitiesTotal: | 3332.5000 | longTermDebt: | 509.8000 |
| shortTermDebt: | 0.0000 | sales: | 7574.4000 |
| netIncome: | 2342.1000 | operatingResult: | 2782.1000 |
| incomeInterest: | 61.5000 | investments: | 3051.1000 |
| incomeTaxes: | 388.3000 | costGoodsSold: | 904.2000 |
| grossProfit: | 6670.2000 | revenuePerEmployee: | 1942153.8462 |
| cashFlow: | 2643.5000 | cashFlowInvesting: | -340.9000 |
| cashFlowFinancing: | -1478.0000 | cashFlowTotal: | 811.2000 |
| accountingStandard: | US GAAP | equityRatio: | 75.1908 |
| debtEquityRatio: | 32.9950 | liquidityI: | 351.3025 |
| liquidityII: | 404.3744 | netMargin: | 30.9213 |
| grossMargin: | 88.0624 | cashFlowMargin: | 34.9005 |
| ebitMargin: | 36.7303 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 27.0337 | preTaxROA: | 20.3268 |
| roe: | 23.1891 | roa: | 17.4361 |
| netIncomeGrowth: | -13.6281 | revenuesGrowth: | 22.0559 |
| taxExpenseRate: | 14.2214 | equityTurnover: | 0.7499 |
| epsBasic: | 9.0900 | epsDiluted: | 9.0100 |
| epsBasicGrowth: | -12.9310 | incomeBeforeTaxes: | 2730.4000 |
| priceEarningsRatioCompany: | 24.1584 | priceCashFlowRatio: | 21.1481 |
| bookValuePerShare: | 39.6737 | marketCap: | 55905041343.6000 |
| earningsYield: | 4.1393 | pegRatio: | -1.8683 |
| cashFlowPerShare: | 10.3839 | priceBookValueRatio: | 5.5352 |
| priceEarningsRatio: | 23.8696 | netEarningsPerShare: | 9.2000 |
| currency: | USD |
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 18150.9000 | cash: | 10504.0000 |
| currentAssets: | 13234.8000 | fixedAssets: | 4916.1000 |
| liabilities: | 2742.1000 | totalLiabilitiesEquity: | 18150.9000 |
| totalShareholdersEquity: | 13912.7000 | property: | 1108.4000 |
| inventories: | 460.6000 | accountsReceivable: | 1442.2000 |
| accountsPayable: | 303.9000 | liabilitiesTotal: | 4238.2000 |
| longTermDebt: | 430.8000 | shortTermDebt: | 0.0000 |
| sales: | 8930.7000 | netIncome: | 3322.0000 |
| operatingResult: | 4307.4000 | incomeInterest: | 54.8000 |
| investments: | 2540.3000 | incomeTaxes: | 910.4000 |
| costGoodsSold: | 1080.3000 | grossProfit: | 7850.4000 |
| cashFlow: | 4129.9000 | cashFlowInvesting: | -321.1000 |
| cashFlowFinancing: | -67.7000 | cashFlowTotal: | 3711.9000 |
| accountingStandard: | US GAAP | equityRatio: | 76.6502 |
| debtEquityRatio: | 30.4628 | liquidityI: | 383.0641 |
| liquidityII: | 435.6588 | netMargin: | 37.1975 |
| grossMargin: | 87.9035 | cashFlowMargin: | 46.2439 |
| ebitMargin: | 48.2314 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 30.4211 | preTaxROA: | 23.3179 |
| roe: | 23.8775 | roa: | 18.3021 |
| netIncomeGrowth: | 41.8385 | revenuesGrowth: | 17.9064 |
| taxExpenseRate: | 21.5103 | equityTurnover: | 0.6419 |
| epsBasic: | 12.9700 | epsDiluted: | 12.8200 |
| epsBasicGrowth: | 42.6843 | incomeBeforeTaxes: | 4232.4000 |
| priceEarningsRatioCompany: | 22.2652 | priceCashFlowRatio: | 17.9769 |
| bookValuePerShare: | 54.1158 | marketCap: | 74242866331.9800 |
| earningsYield: | 4.4913 | pegRatio: | 0.5216 |
| cashFlowPerShare: | 16.0639 | priceBookValueRatio: | 5.3363 |
| priceEarningsRatio: | 22.3488 | netEarningsPerShare: | 12.9215 |
| currency: | USD |
| year: | 2023 | priceEarningsRatioCompany: | 25.4426 |
| priceCashFlowRatio: | 20.5423 | bookValuePerShare: | 54.1158 |
| marketCap: | 84989452484.0000 | earningsYield: | 3.9304 |
| pegRatio: | 0.5961 | cashFlowPerShare: | 16.0639 |
| netAssetsPerShare: | 54.1158 | priceBookValueRatio: | 6.0979 |
| priceEarningsRatio: | 25.5381 | netEarningsPerShare: | 12.9215 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 |
| units: | 1000000 |
| balanceSheetTotal: | 13432.5000 |
| cash: | 6795.0000 |
| currentAssets: | 9560.6000 |
| fixedAssets: | 3871.9000 |
| liabilities: | 2142.0000 |
| totalLiabilitiesEquity: | 13432.5000 |
| totalShareholdersEquity: | 10100.0000 |
| employees: | 3900 |
| property: | 1094.1000 |
| inventories: | 353.1000 |
| accountsReceivable: | 1136.8000 |
| currentSecurities: | 729.9000 |
| accountsPayable: | 195.0000 |
| liabilitiesBanks: | 0.0000 |
| liabilitiesTotal: | 3332.5000 |
| longTermDebt: | 509.8000 |
| shortTermDebt: | 0.0000 |
| sales: | 7574.4000 |
| netIncome: | 2342.1000 |
| operatingResult: | 2782.1000 |
| incomeInterest: | 61.5000 |
| investments: | 3051.1000 |
| incomeTaxes: | 388.3000 |
| costGoodsSold: | 904.2000 |
| grossProfit: | 6670.2000 |
| revenuePerEmployee: | 1942153.8462 |
| cashFlow: | 2643.5000 |
| cashFlowInvesting: | -340.9000 |
| cashFlowFinancing: | -1478.0000 |
| cashFlowTotal: | 811.2000 |
| accountingStandard: | US GAAP |
| equityRatio: | 75.1908 |
| debtEquityRatio: | 32.9950 |
| liquidityI: | 351.3025 |
| liquidityII: | 404.3744 |
| netMargin: | 30.9213 |
| grossMargin: | 88.0624 |
| cashFlowMargin: | 34.9005 |
| ebitMargin: | 36.7303 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 27.0337 |
| preTaxROA: | 20.3268 |
| roe: | 23.1891 |
| roa: | 17.4361 |
| netIncomeGrowth: | -13.6281 |
| revenuesGrowth: | 22.0559 |
| taxExpenseRate: | 14.2214 |
| equityTurnover: | 0.7499 |
| epsBasic: | 9.0900 |
| epsDiluted: | 9.0100 |
| epsBasicGrowth: | -12.9310 |
| incomeBeforeTaxes: | 2730.4000 |
| priceEarningsRatioCompany: | 24.1584 |
| priceCashFlowRatio: | 21.1481 |
| bookValuePerShare: | 39.6737 |
| marketCap: | 55905041343.6000 |
| earningsYield: | 4.1393 |
| pegRatio: | -1.8683 |
| cashFlowPerShare: | 10.3839 |
| priceBookValueRatio: | 5.5352 |
| priceEarningsRatio: | 23.8696 |
| netEarningsPerShare: | 9.2000 |
| currency: | USD |
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 18150.9000 |
| cash: | 10504.0000 |
| currentAssets: | 13234.8000 |
| fixedAssets: | 4916.1000 |
| liabilities: | 2742.1000 |
| totalLiabilitiesEquity: | 18150.9000 |
| totalShareholdersEquity: | 13912.7000 |
| property: | 1108.4000 |
| inventories: | 460.6000 |
| accountsReceivable: | 1442.2000 |
| accountsPayable: | 303.9000 |
| liabilitiesTotal: | 4238.2000 |
| longTermDebt: | 430.8000 |
| shortTermDebt: | 0.0000 |
| sales: | 8930.7000 |
| netIncome: | 3322.0000 |
| operatingResult: | 4307.4000 |
| incomeInterest: | 54.8000 |
| investments: | 2540.3000 |
| incomeTaxes: | 910.4000 |
| costGoodsSold: | 1080.3000 |
| grossProfit: | 7850.4000 |
| cashFlow: | 4129.9000 |
| cashFlowInvesting: | -321.1000 |
| cashFlowFinancing: | -67.7000 |
| cashFlowTotal: | 3711.9000 |
| accountingStandard: | US GAAP |
| equityRatio: | 76.6502 |
| debtEquityRatio: | 30.4628 |
| liquidityI: | 383.0641 |
| liquidityII: | 435.6588 |
| netMargin: | 37.1975 |
| grossMargin: | 87.9035 |
| cashFlowMargin: | 46.2439 |
| ebitMargin: | 48.2314 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 30.4211 |
| preTaxROA: | 23.3179 |
| roe: | 23.8775 |
| roa: | 18.3021 |
| netIncomeGrowth: | 41.8385 |
| revenuesGrowth: | 17.9064 |
| taxExpenseRate: | 21.5103 |
| equityTurnover: | 0.6419 |
| epsBasic: | 12.9700 |
| epsDiluted: | 12.8200 |
| epsBasicGrowth: | 42.6843 |
| incomeBeforeTaxes: | 4232.4000 |
| priceEarningsRatioCompany: | 22.2652 |
| priceCashFlowRatio: | 17.9769 |
| bookValuePerShare: | 54.1158 |
| marketCap: | 74242866331.9800 |
| earningsYield: | 4.4913 |
| pegRatio: | 0.5216 |
| cashFlowPerShare: | 16.0639 |
| priceBookValueRatio: | 5.3363 |
| priceEarningsRatio: | 22.3488 |
| netEarningsPerShare: | 12.9215 |
| currency: | USD |
| year: | 2023 |
| priceEarningsRatioCompany: | 25.4426 |
| priceCashFlowRatio: | 20.5423 |
| bookValuePerShare: | 54.1158 |
| marketCap: | 84989452484.0000 |
| earningsYield: | 3.9304 |
| pegRatio: | 0.5961 |
| cashFlowPerShare: | 16.0639 |
| netAssetsPerShare: | 54.1158 |
| priceBookValueRatio: | 6.0979 |
| priceEarningsRatio: | 25.5381 |
| netEarningsPerShare: | 12.9215 |
| currency: | USD |
